India too should look into mixed dose regime trial, says NITI Aayog member
The Hindu
If proven effective it could go a long way in enhancing faster coverage: V.K. Paul
India can be looking at initiating trials for interchangeability of different COVID-19 vaccines for use to enhance the efficiency of vaccines and offer longer protection, said a senior health official on Monday, while stating that there is currently no specific time line projected for the trials. Speaking about the possibility of a mixed dose regime trial, NITI Aayog member (Health) V.K. Paul said: “There is growing scientific interest in the matter world-wide and India too should look into it. This is a biological plausibility and if proven effective it could go a long way in enhancing faster coverage and acting as a better booster dose that can be offered for use.” Dr. Paul, however, said he wasn’t aware of any specific dates for trial of the proposed regime.More Related News

Vaishnaw credits Make-in-India push for Bengaluru plant after Rahul Gandhi touts Karnataka ecosystem
Vaishnaw credits Make-in-India for Bengaluru's success, acknowledging Rahul Gandhi's praise of Karnataka's thriving business ecosystem.












